Farmeconomia-Health Economics and Therapeutic Pathways

Scope & Guideline

Advancing health economics for a healthier tomorrow.

Introduction

Welcome to your portal for understanding Farmeconomia-Health Economics and Therapeutic Pathways, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageMulti-Language
ISSN1721-6915
PublisherSEED MEDICAL PUBLISHERS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFARMECONOMIA / Farmeconomia
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA MAGENTA, 35, TORINO 10128, ITALY

Aims and Scopes

The journal 'Farmeconomia-Health Economics and Therapeutic Pathways' focuses on the intersection of health economics and therapeutic strategies. It aims to provide insights into the economic aspects of healthcare decisions, emphasizing cost-effectiveness, budget impact, and quality of life assessments in various therapeutic areas.
  1. Health Economics and Pharmacoeconomics:
    The journal emphasizes the economic evaluation of healthcare interventions, including cost-effectiveness analyses and pharmacoeconomic assessments to inform drug pricing and reimbursement decisions.
  2. Health Technology Assessment (HTA):
    It covers comprehensive evaluations of health technologies, assessing their clinical effectiveness, safety, and economic impact, which is essential for informed policy-making.
  3. Real-World Evidence (RWE):
    The journal highlights the importance of real-world evidence in understanding treatment effectiveness and patient outcomes outside controlled clinical trials.
  4. Patient-Centered Outcomes:
    Research often focuses on the impact of treatments on patient quality of life and healthcare resource utilization, ensuring that patient perspectives are central to economic evaluations.
  5. Cost Analysis in Specific Disease Areas:
    The scope includes detailed economic analyses for various diseases, such as diabetes, cancer, and mental health disorders, providing insights into the financial implications of different treatment strategies.
The journal is currently witnessing several emerging themes that reflect the evolving landscape of healthcare economics and therapeutic pathways. These trends highlight the increasing complexity of healthcare decisions and the importance of comprehensive evaluations.
  1. Long-Acting Injectable Therapies:
    There is a growing focus on the clinical and economic potential of long-acting injectable therapies, particularly in mental health and chronic conditions, reflecting a shift towards treatments that improve adherence and outcomes.
  2. Biosimilars and Their Economic Implications:
    Research on biosimilars, including their procurement and budget impact, is trending upward as healthcare systems look for cost-effective alternatives to expensive biologics.
  3. Budget Impact Analyses in Vaccination Programs:
    The importance of budget impact analyses in vaccination strategies, particularly for influenza and other vaccines, is gaining traction as public health priorities shift towards preventative healthcare.
  4. Integrated Care Models and Multi-Disease Approaches:
    Emerging studies are increasingly examining integrated care models that address multiple chronic conditions simultaneously, reflecting a holistic approach to patient management and economic evaluation.
  5. Use of Wearable Health Technologies:
    The assessment of wearable health technologies and their impact on patient management and health outcomes is becoming a prominent theme, driven by advancements in technology and patient engagement.

Declining or Waning

While the journal maintains a robust focus on health economics and therapeutic pathways, certain themes appear to be losing prominence in recent publications. This may reflect shifts in the healthcare landscape or emerging priorities in research.
  1. Traditional Cost-Benefit Analyses:
    There has been a noticeable decline in traditional cost-benefit analyses that do not incorporate broader patient-centered outcomes or real-world evidence, suggesting a shift towards more comprehensive evaluation frameworks.
  2. Generic Drug Assessments:
    Research specifically focused on the economic evaluation of generic drugs seems to be waning, potentially due to a saturation of studies in this area and a preference for innovative therapies.
  3. Single-Disease Focus Studies:
    There appears to be a reduction in studies concentrating solely on single-disease economic evaluations, with an increasing trend toward integrated care models that consider multiple conditions and their interactions.
  4. Basic Economic Modelling Techniques:
    The journal has seen fewer publications relying on basic economic modelling techniques, with a growing preference for sophisticated models that incorporate real-world complexities and uncertainties.

Similar Journals

JOURNAL OF HEALTH ECONOMICS

Shaping the Future of Health Care with Economic Insights
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

Journal of Health Economics and Outcomes Research

Elevating healthcare efficiency through rigorous research.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.

VALUE IN HEALTH

Championing Evidence to Enhance Public Health Strategies
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

AMERICAN JOURNAL OF MANAGED CARE

Advancing managed care knowledge for improved outcomes.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

Pharmacoeconomics-Open

Advancing Access to Critical Health Policy Research
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

Global & Regional Health Technology Assessment

Bridging technology and health for a better tomorrow.
Publisher: ABOUTSCIENCE SRLISSN: 2284-2403Frequency: 1 issue/year

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

Gesundheitsoekonomie und Qualitaetsmanagement

Fostering Excellence in Health Economics and Quality Management
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

MEDICAL DECISION MAKING

Shaping the future of healthcare through evidence-based research.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Applied Health Economics and Health Policy

Unlocking the potential of health economics for global well-being.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Health Economics Review

Advancing insights in health economics and policy.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.